Back to results
US 2026/0055414 A1Published application
Compositions and methods for inhibiting xdh expression
AssigneeNovo Nordisk A/S
InventorsAllison Cherry Ostriker, Martin Lee Koser
Life of this patent
Estimating the term…
Abstract
Oligonucleotides are provided herein that inhibit XDH expression. Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders and/or conditions associated with aberrant XDH expression.
Claims10
A composition comprising a first RNA oligonucleotide and a second RNA oligonucleotide, wherein the first RNA oligonucleotide comprises the sequence set forth in SEQ ID:
- 23, and the second RNA oligonucleotide comprises the sequence set forth in SEQ ID:
- 24.
A composition comprising a first RNA oligonucleotide and a second RNA oligonucleotide, wherein the first RNA oligonucleotide comprises the sequence set forth in SEQ ID:
- 21, and the second RNA oligonucleotide comprises the sequence set forth in SEQ ID:
- 22.
Dependencies are inferred from the claim text.